Jo de la Mare is an Associate Professor in Biochemistry and Head of the Department of Biochemistry, Microbiology and Bioinformatics at Rhodes University, South Africa. She is the Principal Investigator of the FemCR2U (Female Cancers Research at Rhodes University) group. Her research centres around aggressive and treatment-resistant female cancers, with a focus on triple-negative breast cancer, a subtype of the disease that is more prevalent in Black women and cervical cancer, the most prevalent cancer in women in the Eastern Cape. She has been involved in preclinical drug discovery supported by a wide network of national collaborators since 2009, focusing on phenotypic screening and mechanistic analyses. Her group is currently working on establishing and characterizing drug-resistant TNBC cell lines and continuous cervical carcinoma cultures from Eastern Cape women, towards developing more relevant disease models for the African continent. Genetic characterization of the cervical cancer biopsies and continuous cultures aims at developing novel prognostic and diagnostic markers for cervical cancer in African women. She is President of the South African Society of Biochemistry and Molecular Biology, having previously served as Secretary (2018-2022) and Vice-President (2022-2024).
Jo de la Mare is an Associate Professor in Biochemistry and Head of the Department of Biochemistry, Microbiology and Bioinformatics at Rhodes University, South Africa. She is the Principal Investigator of the FemCR2U (Female Cancers Research at Rhodes University) group. Her research centres around aggressive and treatment-resistant female cancers, with a focus on triple-negative breast cancer, a subtype of the disease that is more prevalent in Black women and cervical cancer, the most prevalent cancer in women in the Eastern Cape. She has been involved in preclinical drug discovery supported by a wide network of national collaborators since 2009, focusing on phenotypic screening and mechanistic analyses. Her group is currently working on establishing and characterizing drug-resistant TNBC cell lines and continuous cervical carcinoma cultures from Eastern Cape women, towards developing more relevant disease models for the African continent. Genetic characterization of the cervical cancer biopsies and continuous cultures aims at developing novel prognostic and diagnostic markers for cervical cancer in African women. She is President of the South African Society of Biochemistry and Molecular Biology, having previously served as Secretary (2018-2022) and Vice-President (2022-2024).